Active surveillance of metastatic renal cell carcinoma: Results from a prospective observational study (MaRCC)

Author:

Harrison Michael R.1ORCID,Costello Brian A.2,Bhavsar Nrupen A.1,Vaishampayan Ulka3,Pal Sumanta K.4ORCID,Zakharia Yousef5,Jim Heather S. L.6ORCID,Fishman Mayer N.6,Molina Ana M.7,Kyriakopoulos Christos E.8,Tsao Che‐Kai9,Appleman Leonard J.10,Gartrell Benjamin A.1112,Hussain Arif13,Stadler Walter M.14ORCID,Agarwal Neeraj15,Pachynski Russell K.16,Hutson Thomas E.17,Hammers Hans J.18,Ryan Christopher W.19,Inman Brant A.1ORCID,Mardekian Jack20,Borham Azah20,George Daniel J.1

Affiliation:

1. Duke Cancer Institute Duke University Medical Center Durham North Carolina

2. Division of Medical Oncology Mayo Clinic Rochester Minnesota

3. Karmanos Cancer Institute Detroit Michigan

4. Medical Oncology and Experimental Therapeutics City of Hope Comprehensive Cancer Center Duarte California

5. Department of Medicine University of Iowa Hospitals and Clinics Iowa City Iowa

6. Moffitt Cancer Center Tampa Florida

7. Division of Hematology and Medical Oncology Department of Medicine Weill Cornell Medicine New York New York

8. University of Wisconsin Carbone Cancer Center Madison Wisconsin

9. Tisch Cancer Institute, Mount Sinai Medical Center New York New York

10. The University of Pittsburgh Medical Center (UPMC) Cancer Pavilion Pittsburgh Pennsylvania

11. Department of Medical Oncology Montefiore Medical Center Bronx New York

12. Department of Urology Montefiore Medical Center Bronx New York

13. Department of Medicine University of Maryland Baltimore Maryland

14. Section of Hematology/Oncology Department of Medicine Comprehensive Cancer Center University of Chicago Chicago Illinois

15. Huntsman Cancer InstituteUniversity of Utah Salt Lake City Utah

16. Siteman Cancer Center, Department of Medicine Washington University School of Medicine St Louis Missouri

17. Baylor Sammons Cancer Center‐Texas Oncology Dallas Texas

18. Division of Hematology‐Oncology University of Texas Southwestern Dallas Texas

19. Department of Medicine, Division of Hematology and Medical Oncology Oregon Health and Science University Portland Oregon

20. Pfizer New York New York

Funder

Pfizer

Publisher

Wiley

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3